Filter
387
Text search:
mutation
Featured
Recommendations
49
New Publications
95
Language
Document type
No document type
191
Guidelines
76
Studies & Reports
59
Manuals
18
Strategic & Response Plan
12
Fact sheets
12
Training Material
9
Videos
4
Situation Updates
3
Resource Platforms
2
Brochures
1
Countries / Regions
India
23
Global
11
Western and Central Europe
10
Africa
10
Ethiopia
9
South Africa
9
Burkina Faso
7
Cameroon
7
Latin America and the Carribbean
7
Senegal
6
Congo, Democratic Republic of
6
Haiti
6
Germany
6
Nigeria
5
Nepal
5
Tanzania
4
Benin
4
Liberia
3
Mali
3
Zambia
3
Namibia
3
Middle East and North Africa
3
Eastern Europe
3
Guinea
2
Sierra Leone
2
Côte d’Ivoire / Ivory Coast
2
Morocco
2
Uganda
2
Niger
2
Chad
2
Kenya
2
Rwanda
2
Bangladesh
2
Mozambique
2
Brazil
2
Bolivia
2
Madagascar
2
Russia
2
France
2
Saudi Arabia
1
Togo
1
Zimbabwe
1
Philippines
1
Somalia
1
Iraq
1
Jordan
1
Lebanon
1
Egypt
1
Syria
1
Cambodia
1
Thailand
1
China
1
Indonesia
1
Mauritania
1
Malawi
1
Sudan
1
Central African Republic
1
Argentina
1
Dominican Republic
1
Peru
1
Eswatini/ Swaziland
1
Cuba
1
Ukraine
1
Colombia
1
Honduras
1
Ecuador
1
Botswana
1
El Salvador
1
Libya
1
Guatemala
1
Mexico
1
Nicaragua
1
Myanmar / Burma
1
Chile
1
Yemen
1
East and Southern Africa
1
West and Central Africa
1
South–East Asia Region
1
Asia
1
Venezuela
1
Congo-Brazzaville
1
Qatar
1
Kazakhstan
1
Vietnam
1
Tunisia
1
Spain
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
123
Clinical Guidelines
53
Public Health
26
Pharmacy & Technologies
13
Key Resources
8
Women & Child Health
6
Capacity Building
2
Annual Report MEDBOX
1
Toolboxes
COVID-19
65
TB
50
HIV
25
AMR
22
Rapid Response
15
Mental Health
15
Pharmacy
15
Planetary Health
11
NTDs
11
Ebola
10
NCDs
9
Refugee
7
Caregiver
6
Disability
4
Polio
2
Zika
2
Natural Hazards
1
Specific Hazards
1
Rediscovering Biology
Molecular to Global Perspectives
Accessed: 03.09.2019
French version of "Developing Pharmacy Practice" - WHO/FIP Joint handbook - Ce manuel expose un nouveau paradigme de pratique pharmaceutique. Il a pour but de guider les enseignants en pharmacie pour qu’ils intègrent cette nouvelle pratique pharmaceutique, de former les étudiants
...
Globalization and Health201612:53 DOI: 10.1186/s12992-016-0194-4
Nat Commun 9, 5370 (2018). https://doi.org/10.1038/s41467-018-07804-8. Mycobacterium ulcerans is the causative agent of Buruli ulcer, a neglected tropical skin disease that is most commonly found in children from West and Central Africa. Despite the severity of the infection, therapeutic options are
...
Time has seen management for Cystic Fibrosis (CF) advance drastically, most recently in the development of the disease-modifying triple combination therapy ivacaftor/tezacaftor/elexacaftor. There is currently limited evidence regarding both the global epidemiology of CF and access to this transforma
...
Recommandations pour une approche de santé publique
This guide is a resource for physicians and other health care professionals who provide care and treatment to patients with drug-resistant tuberculosis.
Cet article fait partie d’une série de notes explicatives sur la mise au point et la distribution de vaccins.
The systematic surveillance of antibiotic use and antibiotic re-sistance prevalence in humans and animals is imperative for managingbacterial infectious disease (JPIAMR, 2019;WHO, 2015). Many low-income countries currently face substantial challenges in building national surveillance systems due to
...
Infectious diseases continue to impose unpredictable burdens on global health and economies, a subject that requires constant research and updates. In this sense, the objective of the present article was to review studies on the role of wild animals as reservoirs and/or dispersers of etiological age
...
Exciting new treatment approaches make the management of hepatitic C one of the most rapidly developing areas of medicine. The Flying Publisher short Guide to Hepatitis C is an up-to-date source of information for physicians, residents and advanced medical students.
NATIONAL TUBERCULOSIS AND LEPROSY PROGRAMME
Outil pour la communication comportementale et sociale dans le cadre de la riposte aux flambées épidémiques
WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention approaches.
HIV drug resistance has been rarely reported among PrEP users who tested HIV positive i
...
